Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017 (2017), Article ID 1053617, 10 pages
https://doi.org/10.1155/2017/1053617
Review Article

The Versatile Effects of Dihydromyricetin in Health

1College of Pharmacy, Gannan Medical University, Ganzhou 341000, China
2Jiangxi Health Vocational College, Nanchang 330052, China

Correspondence should be addressed to Qilai Cheng; moc.621@75_lqc and Longhuo Wu; moc.liamtoh@uwhgnol

Received 24 May 2017; Accepted 27 July 2017; Published 30 August 2017

Academic Editor: Siyaram Pandey

Copyright © 2017 Hongliang Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Murakami, M. Miyakoshi, D. Araho et al., “Hepatoprotective activity of tocha, the stems and leaves of Ampelopsis grossedentata, and ampelopsin,” BioFactors, vol. 21, no. 1-4, pp. 175–178, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. L.-P. Ruan, B.-Y. Yu, G.-M. Fu, and D.-N. Zhu, “Improving the solubility of ampelopsin by solid dispersions and inclusion complexes,” Journal of Pharmaceutical and Biomedical Analysis, vol. 38, no. 3, pp. 457–464, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. S.-L. Cao, X. Deng, P. Xu et al., “Highly Efficient Enzymatic Acylation of Dihydromyricetin by the Immobilized Lipase with Deep Eutectic Solvents as Cosolvent,” Journal of Agricultural and Food Chemistry, vol. 65, no. 10, pp. 2084–2088, 2017. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Liu, X. Yin, X. Wang, and X. Li, “Determination of dihydromyricetin in rat plasma by LC-MS/MS and its application to a pharmacokinetic study,” Pharmaceutical biology, vol. 55, no. 1, pp. 657–662, 2017. View at Publisher · View at Google Scholar · View at Scopus
  5. Q. Tong, X. Hou, J. Fang et al., “Determination of dihydromyricetin in rat plasma by LC-MS/MS and its application to a pharmacokinetic study,” Journal of Pharmaceutical and Biomedical Analysis, vol. 114, pp. 455–461, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Xiang, C.-G. Wang, W.-Q. Wang et al., “Gastrointestinal stability of dihydromyricetin, myricetin, and myricitrin: an in vitro investigation,” International Journal of Food Sciences and Nutrition, pp. 1–11, 2017. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Zhang, S. Que, X. Yang, B. Wang, L. Qiao, and Y. Zhao, “Isolation and identification of metabolites from dihydromyricetin,” Magnetic Resonance in Chemistry, vol. 45, no. 11, pp. 909–916, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. X. Li, J. Liu, J. Lin et al., “Protective effects of dihydromyricetin against •OH-induced mesenchymal stem cells damage and mechanistic chemistry,” Molecules, vol. 21, no. 5, article no. 604, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Ye, H. Wang, S. E. Duncan, W. N. Eigel, and S. F. O'Keefe, “Antioxidant activities of Vine Tea (Ampelopsis grossedentata) extract and its major component dihydromyricetin in soybean oil and cooked ground beef,” Food Chemistry, vol. 172, pp. 416–422, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. Q. Song, L. Liu, J. Yu et al., “Dihydromyricetin attenuated Ang II induced cardiac fibroblasts proliferation related to inhibitory of oxidative stress,” European Journal of Pharmacology, vol. 807, pp. 159–167, 2017. View at Publisher · View at Google Scholar
  11. G. Meng, S. Yang, Y. Chen, W. Yao, H. Zhu, and W. Zhang, “Attenuating effects of dihydromyricetin on angiotensin II-induced rat cardiomyocyte hypertrophy related to antioxidative activity in a NO-dependent manner,” Pharmaceutical Biology, vol. 53, no. 6, pp. 904–912, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Mu, Y. Li, B. Liu et al., “Dihydromyricetin Ameliorates 3NP-induced Behavioral Deficits and Striatal Injury in Rats,” Journal of Molecular Neuroscience, vol. 60, no. 2, pp. 267–275, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Liu, D. Zou, K. Chen et al., “Dihydromyricetin Improves Hypobaric Hypoxia-Induced Memory Impairment via Modulation of SIRT3 Signaling,” Molecular Neurobiology, vol. 53, no. 10, pp. 7200–7212, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Wu, Y. Li, H. Song et al., “Preventive effect of dihydromyricetin against cisplatin-induced nephrotoxicity in vitro and in vivo,” Evidence-based Complementary and Alternative Medicine, vol. 2016, Article ID 7937385, 9 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Wang, W. Wang, and E. Qiu, “Protection of oxidative stress induced apoptosis in osteosarcoma cells by dihydromyricetin through down-regulation of caspase activation and up-regulation of BcL-2,” Saudi Journal of Biological Sciences, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Hou, Q. Tong, W. Wang, W. Xiong, C. Shi, and J. Fang, “Dihydromyricetin protects endothelial cells from hydrogen peroxide-induced oxidative stress damage by regulating mitochondrial pathways,” Life Sciences, vol. 130, Article ID 14330, pp. 38–46, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. T. T. Liu, Y. Zeng, K. Tang, X. Chen, W. Zhang, and X. L. Xu, “Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice,” Atherosclerosis, vol. 262, pp. 39–50, 2017. View at Publisher · View at Google Scholar
  18. P. Qiu, Y. Dong, B. Li et al., “Dihydromyricetin modulates p62 and autophagy crosstalk with the Keap-1/Nrf2 pathway to alleviate ethanol-induced hepatic injury,” Toxicology Letters, vol. 274, pp. 31–41, 2017. View at Publisher · View at Google Scholar
  19. R. Wang, J. Pi, X. Su et al., “Dihydromyricetin suppresses inflammatory responses in vitro and in vivo through inhibition of IKKβ activity in macrophages,” Scanning, vol. 38, no. 6, pp. 901–912, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. X. L. Hou, Q. Tong, W. Q. Wang et al., “Suppression of inflammatory responses by dihydromyricetin, a flavonoid from ampelopsis grossedentata, via inhibiting the activation of NF-κB and MAPK signaling pathways,” Journal of Natural Products, vol. 78, no. 7, pp. 1689–1696, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Tang, J. Ma, K. S. Wang et al., “Dihydromyricetin suppresses TNF-α-induced NF-κB activation and target gene expression,” Molecular and Cellular Biochemistry, vol. 422, no. 1-2, pp. 11–20, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Xu, S. Huang, C. Wang, H. Zhang, S. Fang, and Y. Zhang, “Antiinflammatory effects of dihydromyricetin in a mouse model of asthma,” Molecular Medicine Reports, vol. 15, no. 6, pp. 3674–3680, 2017. View at Google Scholar
  23. B. Lin, X. Tan, J. Liang et al., “A reduction in reactive oxygen species contributes to dihydromyricetin-induced apoptosis in human hepatocellular carcinoma cells,” Scientific Reports, vol. 4, p. 7041, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. Zhang, H. Zhang, S. Chen et al., “Dihydromyricetin induces mitochondria-mediated apoptosis in HepG2 cells through down-regulation of the Akt/Bad pathway,” Nutrition Research, vol. 38, pp. 27–33, 2017. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Huang, T. Lian, X. Guan et al., “Dihydromyricetin Reduces TGF-β Via P53 Activation-dependent Mechanism in Hepatocellular Carcinoma HepG2 Cells,” Protein & Peptide Letters, vol. 24, no. 5, pp. 419–424, 2017. View at Publisher · View at Google Scholar
  26. J. Xia, S. Guo, T. Fang et al., “Dihydromyricetin induces autophagy in HepG2 cells involved in inhibition of mTOR and regulating its upstream pathways,” Food and Chemical Toxicology, vol. 66, pp. 7–13, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. B. Liu, W. Zhou, X. Chen et al., “Dihydromyricetin induces mouse hepatoma Hepal-6 cell apoptosis via the transforming growth factor-β pathway,” Molecular Medicine Reports, vol. 11, no. 3, pp. 1609–1614, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. Q.-Y. Zhang, R. Li, G.-F. Zeng et al., “Dihydromyricetin inhibits migration and invasion of hepatoma cells through regulation of MMP-9 expression,” World Journal of Gastroenterology, no. 29, pp. 10082–10093, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Xu, S. Wang, H. F. Chan et al., “Dihydromyricetin Induces Apoptosis and Reverses Drug Resistance in Ovarian Cancer Cells by p53-mediated Downregulation of Survivin,” Scientific Reports, vol. 7, p. 46060, 2017. View at Publisher · View at Google Scholar
  30. Z. Wang, X. Sun, Y. Feng et al., “Dihydromyricetin reverses MRP2-mediated MDR and enhances anticancer activity induced by oxaliplatin in colorectal cancer cells,” Anti-Cancer Drugs, vol. 28, no. 3, pp. 281–288, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. Z. Zhao, J.-Q. Yin, M.-S. Wu et al., “Dihydromyricetin activates AMP-activated protein kinase and P38MAPKexerting antitumor potential in osteosarcoma,” Cancer Prevention Research, vol. 7, no. 9, pp. 927–938, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Zeng, J. Liu, H. Chen et al., “Dihydromyricetin induces cell cycle arrest and apoptosis in melanoma SK-MEL-28 cells,” Oncology Reports, vol. 31, no. 6, pp. 2713–2719, 2014. View at Publisher · View at Google Scholar
  33. H. Huang, M. Hu, R. Zhao, P. Li, and M. Li, “Dihydromyricetin suppresses the proliferation of hepatocellular carcinoma cells by inducing G2/M arrest through the Chk1/Chk2/Cdc25C pathway,” Oncology Reports, vol. 30, no. 5, pp. 2467–2475, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. F. J. Ji, X. F. Tian, X. W. Liu et al., “Dihydromyricetin induces cell apoptosis via a p53-related pathway in AGS human gastric cancer cells,” Genetics and Molecular Research, vol. 14, no. 4, pp. 15564–15571, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. S.-J. Kao, W.-J. Lee, J.-H. Chang et al., “Suppression of reactive oxygen species-mediated ERK and JNK activation sensitizes dihydromyricetin-induced mitochondrial apoptosis in human non-small cell lung cancer,” Environmental Toxicology, vol. 32, no. 4, pp. 1426–1438, 2017. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Zhou, H. Sun, J. Yue, Y. Peng, Y. Chen, and Z. Zhong, “Dihydromyricetin induces apoptosis and cytoprotective autophagy through ROS-NF-κB signalling in human melanoma cells,” Free Radical Research, vol. 51, no. 5, pp. 517–528, 2017. View at Publisher · View at Google Scholar
  37. B. Wu, J. Lin, J. Luo et al., “Dihydromyricetin protects against diabetic cardiomyopathy in streptozotocin-induced diabetic mice,” BioMed Research International, vol. 2017, Article ID 3764370, 2017. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Chen, L. Lv, H. Pi et al., “Dihydromyricetin protects against liver ischemia/reperfusion induced apoptosis via activation of FOXO3a-mediated autophagy,” Oncotarget, vol. 7, no. 47, pp. 76508–76522, 2016. View at Publisher · View at Google Scholar · View at Scopus
  39. T.-F. Fan, T.-F. Wu, L.-L. Bu et al., “Dihydromyricetin promotes autophagy and apoptosis through ROS-STAT3 signaling in head and neck squamous cell carcinoma,” Oncotarget, vol. 7, no. 37, pp. 59691–59703, 2016. View at Publisher · View at Google Scholar · View at Scopus
  40. L. Liu, J. Wan, H. Lang et al., “Dihydromyricetin delays the onset of hyperglycemia and ameliorates insulin resistance without excessive weight gain in Zucker diabetic fatty rats,” Molecular and Cellular Endocrinology, vol. 439, pp. 105–115, 2017. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Shi, T. Zhang, Y. Zhou et al., “Dihydromyricetin improves skeletal muscle insulin sensitivity by inducing autophagy via the AMPK-PGC-1α-Sirt3 signaling pathway,” Endocrine, vol. 50, no. 2, pp. 378–389, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Shi, T. Zhang, X. Liang et al., “Dihydromyricetin improves skeletal muscle insulin resistance by inducing autophagy via the AMPK signaling pathway,” Molecular and Cellular Endocrinology, vol. 409, pp. 92–102, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. Q. Zhou, Y. Gu, H. Lang et al., “Dihydromyricetin prevents obesity-induced slow-twitch-fiber reduction partially via FLCN/FNIP1/AMPK pathway,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol. 1863, no. 6, pp. 1282–1291, 2017. View at Publisher · View at Google Scholar
  44. Q. Zhou, K. Chen, P. Liu et al., “Dihydromyricetin stimulates irisin secretion partially via the PGC-1α pathway,” Molecular and Cellular Endocrinology, vol. 412, pp. 349–357, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. X. Kou, X. Liu, X. Chen et al., “Ampelopsin attenuates brain aging of D-gal-induced rats through miR-34a-mediated SIRT1/mTOR signal pathway,” Oncotarget, vol. 7, no. 46, pp. 74484–74495, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. Z.-X. Ren, Y.-F. Zhao, T. Cao, and X.-C. Zhen, “Dihydromyricetin protects neurons in an MPTP-induced model of Parkinson's disease by suppressing glycogen synthase kinase-3 beta activity,” Acta Pharmacologica Sinica, vol. 37, no. 10, pp. 1315–1324, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. J.-T. Wang, P. Jiao, Y. Zhou, and Q. Liu, “Protective effect of dihydromyricetin against Lipopolysaccharide-Induced acute kidney injury in a rat model,” Medical Science Monitor, vol. 22, pp. 454–459, 2016. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Xie, J. Liu, T.-M. Chen et al., “Dihydromyricetin alleviates carbon tetrachloride-induced acute liver injury via JNK-dependent mechanism in mice,” World Journal of Gastroenterology, vol. 21, no. 18, pp. 5473–5481, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. H.-C. Huang, C.-C. Liao, C.-C. Peng et al., “Dihydromyricetin from Ampelopsis grossedentata inhibits melanogenesis through down-regulation of MAPK, PKA and PKC signaling pathways,” Chemico-Biological Interactions, vol. 258, pp. 166–174, 2016. View at Publisher · View at Google Scholar · View at Scopus
  50. L. Le, B. Jiang, W. Wan et al., “Metabolomics reveals the protective of Dihydromyricetin on glucose homeostasis by enhancing insulin sensitivity,” Scientific Reports, vol. 6, Article ID 36184, 2016. View at Publisher · View at Google Scholar · View at Scopus
  51. C. Xie, Z. Chen, C. Zhang et al., “Dihydromyricetin ameliorates oleic acid-induced lipid accumulation in L02 and HepG2 cells by inhibiting lipogenesis and oxidative stress,” Life Sciences, vol. 157, pp. 131–139, 2016. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Chen, X. Zhao, J. Wan et al., “Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: a randomized controlled trial,” Pharmacological Research, vol. 99, pp. 74–81, 2015. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Liu, Q. Ai, K. Feng, Y. Li, and X. Liu, “The cardioprotective effect of dihydromyricetin prevents ischemia–reperfusion-induced apoptosis in vivo and in vitro via the PI3K/Akt and HIF-1α signaling pathways,” Apoptosis, vol. 21, no. 12, pp. 1366–1385, 2016. View at Publisher · View at Google Scholar · View at Scopus
  54. B. Jiang, L. Le, H. Pan, K. Hu, L. Xu, and P. Xiao, “Dihydromyricetin ameliorates the oxidative stress response induced by methylglyoxal via the AMPK/GLUT4 signaling pathway in PC12 cells,” Brain Research Bulletin, vol. 109, pp. 117–126, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Li, V. K. W. Wong, Z. H. Jiang et al., “Mutation of cysteine 46 in IKK-beta increases inflammatory responses,” Oncotarget, vol. 6, no. 31, pp. 31805–31819, 2015. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Wu, B. Liu, Q. Zhang et al., “Dihydromyricetin reduced bcl-2 expression via p53 in human hepatoma HepG2 cells,” PLoS ONE, vol. 8, no. 11, Article ID e76886, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Williams, C. Ensor, S. Gardner, R. Smith, and R. Lodder, “BSN723T Prevents Atherosclerosis and Weight Gain in ApoE Knockout Mice Fed a Western Diet,” Webmedcentral, vol. 6, no. 12, 2015. View at Google Scholar
  58. P. Hodek, P. Fousova, E. Brabencova et al., “Effect of dihydromyricetin on benzo[a]pyrene activation in rats,” Neuroendocrinology Letters, vol. 35, pp. 158–168, 2014. View at Google Scholar · View at Scopus
  59. Z. Bostikova, M. Moserova, P. Pavek, M. Stiborova, and P. Hodek, “Role of dihydromyricetin in cytochrome P450-mediated metabolism and carcinogen activation,” Neuroendocrinology Letters, vol. 36, no. 2015, pp. 46–52, 2015. View at Google Scholar · View at Scopus
  60. X. Zhu and Y.-H. Jia, “Inhibition of catechol-o-methyltransferase (COMT) by myricetin, dihydromyricetin and myricitrin,” Pharmazie, vol. 69, no. 3, pp. 183–186, 2014. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Liang and R. W. Olsen, “Alcohol use disorders and current pharmacological therapies: The role of GABAA receptors,” Acta Pharmacologica Sinica, vol. 35, no. 8, pp. 981–993, 2014. View at Publisher · View at Google Scholar · View at Scopus
  62. J. Liang, Y. Shen, X. M. Shao et al., “Dihydromyricetin prevents fetal alcohol exposure-induced behavioral and physiological deficits: the roles of GABAA receptors in adolescence,” Neurochemical Research, vol. 39, no. 6, pp. 1147–1161, 2014. View at Publisher · View at Google Scholar · View at Scopus
  63. J. Liang, A. K. Lindemeyer, Y. Shen et al., “Dihydromyricetin ameliorates behavioral deficits and reverses neuropathology of transgenic mouse models of Alzheimer's disease,” Neurochemical Research, vol. 39, no. 6, pp. 1171–1181, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. Y. Wu, J. Bai, K. Zhong, Y. Huang, and H. Gao, “A dual antibacterial mechanism involved in membrane disruption and DNA binding of 2R,3R-dihydromyricetin from pine needles of Cedrus deodara against Staphylococcus aureus,” Food Chemistry, vol. 218, pp. 463–470, 2017. View at Publisher · View at Google Scholar · View at Scopus
  65. Y.-H. Huang, C.-C. Huang, C.-C. Chen, K.-J. Yang, and C.-Y. Huang, “Inhibition of Staphylococcus aureus PriA Helicase by Flavonol Kaempferol,” Protein Journal, vol. 34, no. 3, pp. 169–172, 2015. View at Publisher · View at Google Scholar · View at Scopus
  66. C.-Y. Huang, “Inhibition of a putative dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by flavonoids and substrates of cyclic amidohydrolases,” PLoS ONE, vol. 10, no. 5, Article ID e0127634, 2015. View at Publisher · View at Google Scholar · View at Scopus
  67. W. Zhang, S. Wang, H. Yin et al., “Dihydromyricetin enhances the osteogenic differentiation of human bone marrow mesenchymal stem cells in vitro partially via the activation of Wnt/β-catenin signaling pathway,” Fundamental and Clinical Pharmacology, vol. 30, no. 6, pp. 596–606, 2016. View at Publisher · View at Google Scholar · View at Scopus
  68. L. Jiang, Q. Zhang, H. Ren et al., “Dihydromyricetin enhances the chemo-sensitivity of nedaplatin via regulation of the p53/Bcl-2 pathway in hepatocellular carcinoma cells,” PLoS ONE, vol. 10, no. 4, Article ID e0124994, 2015. View at Publisher · View at Google Scholar · View at Scopus
  69. J. Liu, Y. Shu, Q. Zhang et al., “Dihydromyricetin induces apoptosis and inhibits proliferation in hepatocellular carcinoma cells,” Oncology Letters, vol. 8, no. 4, pp. 1645–1651, 2014. View at Publisher · View at Google Scholar · View at Scopus
  70. Q. Zhang, J. Liu, B. Liu et al., “Dihydromyricetin promotes hepatocellular carcinoma regression via a p53 activation-dependent mechanism,” Scientific Reports, vol. 4, article no. 4628, 2014. View at Publisher · View at Google Scholar · View at Scopus
  71. H. Zhu, P. Luo, Y. Fu et al., “Dihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin,” Oncotarget, vol. 6, no. 5, pp. 3254–3267, 2015. View at Publisher · View at Google Scholar · View at Scopus